Clinical Trials Logo

Anxiety Disorders clinical trials

View clinical trials related to Anxiety Disorders.

Filter by:
  • Active, not recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06410794 Active, not recruiting - Depression Clinical Trials

Virtual Reality Training in Occupational Rehabilitation

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

Work-related attention bias modification training and virtual reality training in occupational rehabilitation is a multisite pilot study. The quantitative aim of this pilot study is to compared virtual reality (VR) training and attention bias modication (ABM) training to investigate whether the different training forms result in different results measured with work-related outcomes and cognitive outcomes. The qualitative aim of this pilot study is to investigate the patients' experiences with the usage of VR. Three rehabilitation insitutions will be recruiting patients participating in occupational rehabilitation, and the study will compare the outcomes of work-related interventions with and without the addition of ABM or VR training. The study seeks to determine if these interventions can improve work ability, reduce symptoms of depression and anxiety, and change attentional bias from negative to positive stimuli.

NCT ID: NCT06292247 Active, not recruiting - Dental Anxiety Clinical Trials

Effectiveness of CBT and APT on Managing Child Anxiety in Dental Office

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

This study was conducted to the Effectiveness of Cognitive Behavioral Therapy and Auricular Plaster Therapy on Managing Child Anxiety in Dental Office.

NCT ID: NCT06279091 Active, not recruiting - Dental Anxiety Clinical Trials

Correlation of Children and Parental Anxiety and Effectiveness of Breathing Exercises on Anxiety Reduction

Start date: May 23, 2023
Phase: N/A
Study type: Interventional

The purpose of this study to evaluate the correlation between children and parental dental anxiety as well as to evaluate the effectiveness of breathing exercises on anxiety reduction.

NCT ID: NCT06264050 Active, not recruiting - Anxiety Clinical Trials

Psychological Support Group and Its Effects on Mood, Anxiety and Coping

SUPPORT
Start date: January 8, 2004
Phase: N/A
Study type: Interventional

The aim of this study is to verify the influence that participation in a Psychological Support Group has on anxiety, depression and coping skills in patients admitted to the IRCCS San Camillo Hospital. It is therefore an observational study with a pre-post design on a cohort of patients hospitalized at San Camillo IRCCS who attend the Psychological Support Group. The study consists of verifying whether the therapeutic activity of the Psychological Support Group (GSP) has an influence on the levels of anxiety, mood and coping skills in the patients who attend it. These purposes will be pursued through the administration to each patient at the beginning (pre) and at the end (post) of the period of attendance at the GSP, of validated scales: Stay Y2 (anxiety), BDI II(depressive symptoms), COPE NVD 25 (coping strategies) and the CORE-OM (outcomes of psychological activity).

NCT ID: NCT06122883 Active, not recruiting - Anesthesia, Local Clinical Trials

Dental Attire Effect on Children's Dental Anxiety

Start date: January 15, 2023
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the effect of friendly attire on dental anxiety among children visiting dental office in comparison with conventional attire. All of the children who will be experienced maxillary dental anesthesia with/without distraction will be assessed by using a combination of measures: Wong-Baker faces and the Children's Fear Scale (self-report), heart pulse rate, and behavior (using Anxiety levels using Face - Legs - Activity - Cry - Consolability "FLACC" scale "external evaluator") Acceptance will be measured using a two-point Likert scale.

NCT ID: NCT06119854 Active, not recruiting - Depression Clinical Trials

Brief Digital Intervention to Increase COVID-19 Vaccination Among Individuals With Anxiety or Depression

Start date: April 15, 2024
Phase: N/A
Study type: Interventional

The COVID-19 pandemic has led to a mis/disinformation ecosystem that promotes divergent views of vaccine efficacy, as well as the legitimacy of science and medicine. Individuals are confronted with vaccine-related information from a multitude of sources, posing a challenge to identifying inaccurate information. COVID-19 vaccine uptake is lower among people with anxiety and depression than in the general population, due in part to higher levels of vaccine hesitancy. The prevalence of anxiety and depressive symptoms among US adults increased significantly during the COVID pandemic and has remained elevated. Interventions capable of mitigating the impact of vaccine hesitancy and mis/disinformation among undervaccinated people with anxiety or depression are therefore an urgent priority. Emerging evidence suggests that reasons for vaccine hesitancy and the impact of conventional vaccination messaging differ between those with and without mental health symptoms. There may also be added challenges overcoming logistical barriers to vaccination for people with anxiety or depressive symptoms. The investigators aim to determine the effectiveness of two different brief digital intervention strategies compared with conventional public health messaging for increasing vaccine uptake in undervaccinated adults with and without anxiety or depressive symptoms. Attitudinal inoculation is a brief, scalable strategy that leverages the power of narrative, values, and emotion to strengthen resistance to mis/disinformation and reduce hesitancy. Though this approach has been shown to decrease COVID-19 vaccine hesitancy among US adults, the extent to which this approach increases COVID-19 vaccination remains unknown. Cognitive-behavioral therapy (CBT) is an evidence-based intervention for anxiety and depression. However, the efficacy of incorporating CBT-informed messaging in a vaccine promotion intervention has not been tested. The investigators hypothesize that both attitudinal inoculation and CBT-style communication will be more effective than conventional public health messaging to increase COVID-19 vaccination. The investigators also hypothesize that the CBT-informed intervention will be more effective than the attitudinal inoculation intervention for increasing COVID-19 vaccination among participants with symptoms of anxiety or depression.

NCT ID: NCT06063265 Active, not recruiting - Anxiety Clinical Trials

Effect of a Six-week Integrated Attention Training Program on the Cognitive Functions of Older Adults With Co-occurring Anxiety Symptoms and Subjective Cognitive Complaints

Start date: July 1, 2023
Phase: N/A
Study type: Interventional

The goal of this single-blind randomized control trial is to compare a 6-week Integrated Attention Training Program (IATP) and health education in older people with co-occurrence of anxiety symptoms and subjective cognitive decline (SCC). The study aims to answer if a 6-week Integrated Attention Training Program (IATP) will improve cognitive, anxiety, and level of pro-inflammatory biomarkers in this high-risk group. Older adults with co-occurring anxiety and SCC will be recruited to participate in a 6-week single-blind randomized controlled trial. IATP group (Intervention group) will undergo attention and functional training. Control group will receive health education. Investigators will compare the IATP with health education to see if cognitive function, anxiety symptoms, and level of pro-inflammatory biomarkers in comparison to health education will improved after intervention and over 24 weeks.

NCT ID: NCT06016907 Active, not recruiting - Anxiety Disorders Clinical Trials

Stepped vs Stratified Care for Pediatric Anxiety Disorders

PMAX
Start date: October 2, 2023
Phase: N/A
Study type: Interventional

The purpose of this trial is to evaluate the feasibility, acceptability, and safety of two care pathways (including internet-delivered cognitive behavioral therapy [CBT] and/or in-person CBT) for children and adolescents with anxiety disorders.

NCT ID: NCT05982288 Active, not recruiting - Anxiety Clinical Trials

Investigation of the Effect of Virtual Reality Software on Nurses' Clinical Practice, Problem Solving and Clinical Decision Making Skills and Anxiety in the Care Management of Intensive Care Patients.

Start date: July 1, 2023
Phase: N/A
Study type: Interventional

In the light of technological developments, learner-centered methods have begun to replace traditional teaching methods. Simulation applications are increasing in order to ensure patient safety and improve the quality of care in the training of nurses. Virtual reality, which is one of the simulation applications, is defined as an interactive, fun and virtual environment with three-dimensional visual feedback consisting of different sensory stimuli, where computer software and hardware are used together. When the studies on virtual reality, which is seen as a treatment, care and education tool in health care services, are examined; It is seen that virtual reality is mostly used in the teaching of some basic skills and in the education of nursing/medical students. From this point of view, in this project, which was submitted to the proposal, it was aimed to develop a virtual reality software for the care management of the intensive care patient and to investigate the effect of this software on the new intensive care nurses. Nurses to be included in the study will be randomly assigned to the control (n=34) and study groups (n=34). The research will be carried out in the following steps: 1) According to Kolcaba's Comfort Theory, the patient case scenario including the care management of the intensive care patient will be prepared and transferred to the virtual reality software, 2) The nurses in both groups will be given theoretical training on the care management of the intensive care patients, 3) The nurses forming the control group will be given theoretical training. A routine orientation training program will be given, and virtual reality glasses will be applied to the study group 4) "Knowledge Level Questionnaire", "Clinical Practice Skill Observation Form", "Problem Solving" before the theoretical training, 1 week after the application and in the first month of the application for both groups. Inventory", "Clinical Decision Making Scale in Nursing", "State Anxiety Inventory" and "Satisfaction Level Questionnaire" will be applied. With the software planned to be developed within the scope of the project, it is predicted that patient comfort and quality of life in intensive care will increase by providing rapid orientation to the clinic of the new intensive care nurses and increasing their clinical practice, problem solving and clinical decision making skills.

NCT ID: NCT05930912 Active, not recruiting - Anxiety Disorders Clinical Trials

Psychiatric Orders in Psychoanalytic Treatment of ASD

Start date: June 1, 2023
Phase:
Study type: Observational

Autism Spectrum Disorder (ASD) is often accompanied by a variety of other symptoms, such as bipolar disorder, Attention Deficit Hyperactivity Disorder (ADHD), Social Anxiety Disorder (SAD), Avoidant Personality Disorder (AvPD), Obsessive Compulsive Disorder (OCD), etc. The behavioral and social complications often marginalize the population, impact on life satisfaction, undermined societal values that impact on economic and financial fairness, and so forth. Furthermore, persons with ASD are neurodiverse from standardized pharmacological and clinical cares, and are interpreted disadvantaged in the context of neurotypical treatments. The research protocol aims to differentiate the neuropharmacological implications of ASD from its behavioral and social implications. Such a differentiation is beneficial to the quality of care for neurodiverse population, both in terms of precision treatment in medical settings, and in terms of psychotherapeutic treatment efficacy in the interpretation of behavioral and social traits. The study protocol continues from the adverse event of the participant in NCT05711810 trial, after the positive immunological results in the NCT05839236 trial. The intervention medicine continues from Sertraline adjusted on the choice of Selective Serotonin Reuptake Inhibitor (SSRI) in the previous two trials for complex post-traumatic stress disorder (CPTSD) of the participant, and its combined used with Duloxetine in the choice of Selective Norephedrine Reuptake Inhibitor (SNRI) for norephedrine regulations. The hypothesized target is on the discrete psychiatric intervention centered approach to ASD treatment care. In the PRC where the study is being carried out, amphetamine class medicines are strictly prohibited and defined as illegal substances, regardless of their only proven effect for ASD patient care. Contributed by the sociostructural elements and necessities, black market amphetamine and ketamine have not only emerged in the regime for decades, but also have become a lucrative business. Their recreational uses are also sometimes accompanied by real necessities and needs; black markets cater to the needs but guidance on the usages is based on word-of-mouth stories without professional medical assistances. There is one case the Principal Investigator (PI) collected, that one person, possibly under depression contributed by PTSD, took relatively high dosage of amphetamine and went into a state of psychosis with overwhelming persecution mania. The study protocol, Psychiatric Orders in Psychoanalytic Treatment of ASD, is therefore designed for an evidence-based approach in treating complex psychiatric disorders with psychoanalytic guidance.